US Patent 11969544 | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
NEW Find Prospects
- Prospector
Drugs in Dev.
News
Blog
Market Place
Login

Teva Pharmaceutical Industries

Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

Contact Supplier

Evonik Health Care is the innovation hub for leading life science companies

Contact Supplier

Aarti Pharmalabs is a partner of choice for pharmaceutical companies for APIs & Intermediates. Largest Indian producer of Caffeine.

Contact Supplier

Axplora is your partner of choice for complex APIs.

Contact Supplier

Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

Contact Supplier

pharmacompass-2-2026-02-09

Teva Pharmaceutical Industries

VIRTUAL BOOTH, Contact Details

VIRTUAL BOOTH
CONTACT DETAILS
Google Map, LinkedIn, Emails...

EVENTS

Webinars & Exhibitions

Webinars & Exhibitions

DIGITAL CONTENT

Interview #SpeakPharma, Vlog #PharmaReel, Data Compilation #PharmaFlow, 2249 News #PharmaBuzz

Interview #SpeakPharma
Vlog #PharmaReel
Data Compilation #PharmaFlow
2249 News #PharmaBuzz

ACTIVE PHARMA INGREDIENTS

548 All APIs, 95 USDMF, 9 CEP/COS, 63 JDMF, 104 KDMF, 152 NDC API, 1 VMF, 269 Listed APIs

548 All APIs
95 USDMF
9 CEP/COS
63 JDMF
104 KDMF
152 NDC API
1 VMF
269 Listed APIs

DEVELOPMENTS

412 Drugs in Development

412 Drugs in Development

FINISHED DOSAGE FORMULATIONS

8934 FDF Dossiers, 2251 FDA Orange Book, 5514 Europe, 739 Canada, 182 Australia, 247 South Africa, 1 Listed Dossiers

8934 FDF Dossiers
2251 FDA Orange Book
5514 Europe
739 Canada
182 Australia
247 South Africa
1 Listed Dossiers

EXCIPIENTS

1 All Excipients, 1 USDMF

1 All Excipients
1 USDMF

REF. STANDARDS & IMPURITIES

1 Others

1 Others

INSPECTIONS & REGISTRATIONS

206 FDA, 68 EDQM, 2 WHO-GMP, 27 GDUFA, 8 Third-Party Audit

206 FDA
68 EDQM
2 WHO-GMP
27 GDUFA
8 Third-Party Audit

Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

14 All

01 14TEVA PHARM

filter Patent Number Reset all filters

14 All

01 1411969544

API Patent Reset all filters

14 All

01 14Blank

filter FDF Patent Reset all filters

14 All

01 14Y

filter Expiration Date Reset all filters

14 All

01 142039-08-20

01

TEVA PHARM

FLUTICASONE PROPIONATE

BePharma

Not Confirmed

TEVA PHARM

BePharma

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2039-08-20

FLUTICASONE PROPIONATE

US Patent Number : 11969544

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 208798

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2039-08-20

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

TEVA PHARM

FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE

BePharma

Not Confirmed

TEVA PHARM

BePharma

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2039-08-20

FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE

US Patent Number : 11969544

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 208799

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2039-08-20

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

TEVA PHARM

FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE

BePharma

Not Confirmed

TEVA PHARM

BePharma

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2039-08-20

FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE

US Patent Number : 11969544

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 208799

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2039-08-20

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

TEVA PHARM

FLUTICASONE PROPIONATE

BePharma

Not Confirmed

TEVA PHARM

BePharma

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2039-08-20

FLUTICASONE PROPIONATE

US Patent Number : 11969544

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 208798

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2039-08-20

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

TEVA PHARM

FLUTICASONE PROPIONATE

BePharma

Not Confirmed

TEVA PHARM

BePharma

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2039-08-20

FLUTICASONE PROPIONATE

US Patent Number : 11969544

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 208798

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2039-08-20

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

TEVA PHARM

FLUTICASONE PROPIONATE

BePharma

Not Confirmed

TEVA PHARM

BePharma

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2039-08-20

FLUTICASONE PROPIONATE

US Patent Number : 11969544

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 208798

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2039-08-20

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

TEVA PHARM

FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE

BePharma

Not Confirmed

TEVA PHARM

BePharma

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2039-08-20

FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE

US Patent Number : 11969544

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 208799

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2039-08-20

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

TEVA PHARM

FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE

BePharma

Not Confirmed

TEVA PHARM

BePharma

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2039-08-20

FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE

US Patent Number : 11969544

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 208799

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2039-08-20

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

09

TEVA PHARM

FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE

BePharma

Not Confirmed

TEVA PHARM

BePharma

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2039-08-20

FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE

US Patent Number : 11969544

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 208799

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2039-08-20

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

10

TEVA PHARM

FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE

BePharma

Not Confirmed

TEVA PHARM

BePharma

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2039-08-20

FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE

US Patent Number : 11969544

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 208799

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2039-08-20

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

1
2

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.